The data confirmed again that DNMT3a enrichment at the CREMα promoter was remarkably reduced in CD4+ T cells from SLE patients (Fig. 7c), and it was positively correlated with the SUV39H1 binding (Fig. 7d). This evidence concerns the gene DNMT3A and systemic lupus erythematosus.